Drug
Suboxone Sublingual Film
Suboxone Sublingual Film: highest development phase Post-Market, developed by Indivior. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| Suboxone Sublingual Film NCT02038790 | Post-Market | Opioid Dependence |
| SUBOXONE sublingual film NCT02510014 | Phase 3 | Opioid Use Disorder |
Latest
No recent events.
Follow Suboxone Sublingual Film on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.